Bringing the Future of Diabetes Care Worldwide
Semaglutide API & Oral Finished Dose Formulation
API + Oral Formulation available for licensing & partnerships worldwide
FDA Approved DMF
Global Licensing & Supply
Proven Quality & Innovation
Does this sound familiar?
Regulatory Barriers: Navigating approvals and compliance for Semaglutide can be complex and time-consuming.
Limited Supply: Access to consistent, high-quality Semaglutide API is a major challenge worldwide.
High Costs & Delays: Unreliable access often leads to higher costs and slower market entry.
With Covalence Pharma. You’ll get…
FDA-Approved DMF → Compliance you can trust.
Global Supply & Licensing → Reliable, scalable access.
Trusted Partner → Reduce risk, save time, and accelerate commercialization.
Copyright © 2025 Covalence Pharma. All rights reserved
LinkedIn
WhatsApp